Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 03 Sep 2024

'Cured Sore Throat, Neck Pain': Chinese Diplomat All Praise For Indian Medicines

NDTV Profit

Yu Jing's post quickly gained traction, garnering over 5,50,000 views, with many users also sharing their own positive experiences with 'cheaper' and 'effective' Indian medicines.

Pharmaceuticals & Biotech.

SECTOR | 29 Aug 2024

Pharma Sector Q1 Results Review - Select Bets To Continue To Perform: DRChoksey

NDTV Profit

Profitability continues to grow at a strong pace aided by improved products mix and lower raw materials costs for the brokerage's coverage universe.

Pharmaceuticals & Biotech.

SECTOR | 19 Aug 2024

Aurobindo Pharma to commercialise China plant in 3rd quarter of FY25: CFO

Business Standard

Aurobindo Pharma expects its China facility to commence production in the next quarter with full-scale output anticipated only in the next fiscal year, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug major plans to start a small volume roll out in the November-December period and expects to ramp it up in the January-March quarter of the next year. "Our China plant is expected to be commercialised from Q3 FY25, and the ramp up is expected from Q4 FY25," Subramanian said in an analyst call. The full-fledged volume production will start at the facility in FY26, he stated. "We are trying to do some filings for China as well as for the US. So all this will take the China revenue potential up in the coming years. This year, we will see only a small volume and value," Subramanian stated. He noted that the company is also on track with respect to large-scale commercialisation of Pen-G (penicillin). The company is hopeful to ramp up production signific

Pharmaceuticals & Biotech.

SECTOR | 18 Aug 2024

Tripura CM launches intensified awareness campaign to control HIV/AIDS

Business Standard

Tripura Chief Minister Manik Saha launched a state-wide intensified information education and communication (IEC) campaign to raise mass awareness among the people of the state about HIV and AIDS. Launching the campaign on Saturday, the CM stressed on the importance of public awareness and precautionary measures needed to check and control the spread of HIV infection. Before launching the awareness programme, Saha held a review meeting on HIV/AIDS-related issues at the Civil Secretariat on Saturday. "Chaired a review meeting of the Tripura State AIDS Control Society at the Secretariat, discussing progress, challenges, and future strategies to combat HIV/AIDS in the state. The meeting discussed the progress, challenges and future strategies to combat HIV/AIDS in the state. "Committed to ensuring quality healthcare and support services to all and achieve the target of ending HIV/ AIDS by 2030!" the chief minister said in a post on X. In the meeting, the CM said, "Students from schoo

Pharmaceuticals & Biotech.

SECTOR | 07 Aug 2024

Separate marketing code: Medical devices industry welcomes govt's move

Business Standard

A separate marketing practices code has been a long-standing demand for medical devices. Currently, the industry has to comply with the marketing practices code for pharmaceuticals

Pharmaceuticals & Biotech.

SECTOR | 05 Aug 2024

Lupin completes Phase III global trial on biosimilar of Lucentis

Business Line

Data from the study would be part of Lupin's application for marketing approval with the US Food and Drug Administration and the European Medicines Agency

Pharmaceuticals & Biotech.

SECTOR | 04 Aug 2024

Reading the vital signs: Pharma sector, the market's trusted antidote

Business Standard

The pharma index was the only healthy pulse amid Friday's market declines

Pharmaceuticals & Biotech.

SECTOR | 30 Jul 2024

USFDA scrutiny delays generic drug approvals for major Indian pharma firms

Business Standard

Big Pharma companies Cipla, Sun Pharma, Aurobindo Pharma, Dr Reddy's, and Lupin face intense scrutiny from the US Food and Drug Administration (USFDA)

Pharmaceuticals & Biotech.

SECTOR | 29 Jul 2024

AIDS response waning

Business Line

Globally, there's a spike in new infection rates

Pharmaceuticals & Biotech.

SECTOR | 24 Jul 2024

HIV medicine that costs $42,000 could be made for just $40 with profits

Business Standard

Lenacapavir drug hailed as 'the closest we have ever been to an HIV vaccine', is currently sold by US pharma major Gilead at Rs $42,250 for the first year